D'INZEO, SONIA
 Distribuzione geografica
Continente #
NA - Nord America 873
EU - Europa 247
AS - Asia 104
AF - Africa 6
SA - Sud America 6
Totale 1.236
Nazione #
US - Stati Uniti d'America 870
IT - Italia 84
IN - India 43
SE - Svezia 43
UA - Ucraina 37
SG - Singapore 34
CN - Cina 26
DE - Germania 22
FI - Finlandia 20
GB - Regno Unito 11
BE - Belgio 7
BG - Bulgaria 6
NL - Olanda 5
AR - Argentina 4
FR - Francia 4
TG - Togo 4
CA - Canada 3
IE - Irlanda 2
BR - Brasile 1
ES - Italia 1
JO - Giordania 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 1.236
Città #
Fairfield 135
Ann Arbor 83
Woodbridge 70
Chandler 69
Ashburn 54
Seattle 52
Wilmington 47
Houston 44
Cambridge 40
Rome 32
Princeton 24
Singapore 20
Plano 19
Dearborn 16
Beijing 14
Jacksonville 14
Lawrence 14
San Paolo di Civitate 14
Des Moines 10
Fremont 8
Andover 7
Grafing 7
Los Angeles 7
Boston 6
Cagliari 6
Dallas 6
Millbury 6
New York 6
San Diego 6
Sofia 6
Auburn Hills 5
Boardman 5
Brussels 5
Bremen 4
Federal 4
Helsinki 4
Lomé 4
Milan 4
Indiana 3
Misterbianco 3
Norwalk 3
Phoenix 3
San Benedetto del Tronto 3
Santa Clara 3
Toronto 3
Anzio 2
Arezzo 2
Bühl 2
Chennai 2
Civate 2
Civitanova Marche 2
Dublin 2
Guangzhou 2
Italy 2
Laurel 2
Nanjing 2
Redmond 2
Waanrode 2
Amman 1
Benevento 1
Ermont 1
Groningen 1
Hefei 1
Islington 1
Jinan 1
Kunming 1
London 1
Luxembourg 1
L’Aquila 1
Muizenberg 1
Naples 1
Ningbo 1
Provo 1
Puszcza Marianska 1
Richmond 1
Riga 1
San Jose 1
San Mateo 1
Shenyang 1
Trujillo 1
Westminster 1
Xian 1
Totale 948
Nome #
Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer. 121
Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14. 93
Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer 88
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families 87
Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data 83
The role of peroxiredoxins in cancer 78
A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression 77
Peroxiredoxin 2 nuclear levels are regulated by circadian clock synchronization in human keratinocytes 67
The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration 65
EGF and TGF-β1 effects on thyroid function 63
SMAD NUCLEOCYTOPLASMIC SHUTTLING IN THE THYROID TUMORIGENESIS. 56
Role of reduced expression of SMAD4 in papillary thyroid carcinoma 54
PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms 52
The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals 50
Effects of the Smad4 C324Y mutation on thyroid cell proliferation 48
Role of Smads in the tumorigenicity and metastatic potential of K-ras transformed thyroid cells. 47
Increased expression of cyclin D1 is associated with impairment of TGFb-growth inhibitory signal at the level of either type II receptor (TbRII) or Smad proteins in Ras-transformed rat thyroid cells and in human thyroid tumours.. 44
Ruolo delle alterazioni di Smad4 nelle patologie neoplastiche tiroidee 39
TGF-b1 signalling in K-ras transformed thyroid cells 34
Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway 30
Totale 1.276
Categoria #
all - tutte 3.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.501


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020303 0 0 4 14 30 46 62 49 37 34 19 8
2020/2021105 9 18 4 2 0 16 4 4 11 32 4 1
2021/2022195 3 13 22 4 25 3 4 23 11 15 40 32
2022/2023242 44 55 21 18 25 42 0 11 15 1 8 2
2023/2024110 6 14 3 7 8 15 5 11 2 20 8 11
2024/202531 15 6 10 0 0 0 0 0 0 0 0 0
Totale 1.276